Summary by Moomoo AI
Kingsway Biotechnology Co., Ltd. filed with Hong Kong Trading and Settlement Limited on 6 March 2024 with Hong Kong Trading and Settlement Limited, covering data for the year ended 29 February 2024. The report shows that the company's regulary/registered share capital and issued shares remained unchanged during the month. The deposit amount of ordinary shares remained at 5,000,000,000 shares, with a face value of $0.001 per share and a total regulated/registered share capital of $5,000,000. In addition, the Company's stock option plan includes a stock option plan before and after the initial public offering. The number of stock options is unchanged at 40,011,984 shares and 45,029,457 shares, respectively, and the total number of new shares may be issued of 82,090,141 shares. No funds received during this month as a result of exercising options. The report was presented by Director Meng Jiankang.